A Look At Cencora (COR) Valuation After 2026 Guidance Update And New CAR T Distribution Deal

Simply Wall St.06-08 05:19

Cencora (COR) is back on investors’ radar after updating its fiscal 2026 outlook, raising adjusted EPS expectations while projecting lower revenue growth, along with a new CAR T distribution agreement...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2641007179?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/24809-main-header/1756252652273","is_english":true,"pubTime":"2026-06-08 05:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2641007179","market":"sg","top_or_hot":-1,"title":"A Look At Cencora (COR) Valuation After 2026 Guidance Update And New CAR T Distribution Deal","media":"Simply Wall St.","content":"<div>\n<p>Cencora (COR) is back on investors’ radar after updating its fiscal 2026 outlook, raising adjusted EPS expectations while projecting lower revenue growth, along with a new CAR T distribution agreement...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/a-look-at-cencora-cor-valuation-after-2026-guidance-update-a\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Cencora (COR) Valuation After 2026 Guidance Update And New CAR T Distribution Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Cencora (COR) Valuation After 2026 Guidance Update And New CAR T Distribution Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-08 05:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/a-look-at-cencora-cor-valuation-after-2026-guidance-update-a><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cencora (COR) is back on investors’ radar after updating its fiscal 2026 outlook, raising adjusted EPS expectations while projecting lower revenue growth, along with a new CAR T distribution agreement...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/a-look-at-cencora-cor-valuation-after-2026-guidance-update-a\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1814569148.SGD","symbol_name":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/a-look-at-cencora-cor-valuation-after-2026-guidance-update-a","article_id":"2641007179","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/24809-main-header/1756252652273"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cor/cencora/news/a-look-at-cencora-cor-valuation-after-2026-guidance-update-a","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2641007179","pubTimestamp":1780867170,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Cencora (COR) is back on investors’ radar after updating its fiscal 2026 outlook, raising adjusted EPS expectations while projecting lower revenue growth, along with a new CAR T distribution agreement with Kite, a Gilead Company.\nSee our latest analysis for Cencora.\nThe updated fiscal 2026 guidance and CAR T agreement appear to have helped the share price regain some ground in the short term, with a 1 month share price return of 5.35%. However, momentum has cooled, with a 3 month share price...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","BK4084":"特种房地产投资信托","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","BK4529":"IDC概念","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","BK4022":"陆运","BK4175":"保健护理产品经销商","BK4230":"旅客陆运","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","CAR":"安飞士","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4588":"碎股","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU0058720904.USD":"联博国际健康护理基金A","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","COR":"CENCORA","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC"},"translate_title":"2026年指导更新和新车T分销协议后Cencora(COR)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAR":1.5,"COR":1.5},"content_text":"Cencora (COR) is back on investors’ radar after updating its fiscal 2026 outlook, raising adjusted EPS expectations while projecting lower revenue growth, along with a new CAR T distribution agreement with Kite, a Gilead Company. See our latest analysis for Cencora. The updated fiscal 2026 guidance and CAR T agreement appear to have helped the share price regain some ground in the short term, with a 1 month share price return of 5.35%. However, momentum has cooled, with a 3 month share price decline of 23.98% and a 1 year total shareholder return of 4.09% in the red, compared with a much stronger 3 year total shareholder return of 58.35% and 5 year total shareholder return of 141.64%. If this kind of healthcare logistics story interests you, it can be useful to see what else is moving by checking out 39 healthcare AI stocks With Cencora trading at $275.04 and management guiding to higher adjusted EPS despite softer revenue growth, plus a fresh CAR T distribution deal, should you view the current price as a potential entry point, or conclude that the market is already fully reflecting expectations for future growth? AdvertisementMost Popular Narrative: 22.9% Undervalued Against Cencora's last close of $275.04, the most followed narrative pegs fair value at $356.83 per share, using a 7.11% discount rate and detailed long term earnings assumptions.  Cencora's ongoing investment in digital infrastructure and advanced analytics positions the company to capitalize on the accelerating digitization of healthcare and regulatory requirements like the Drug Supply Chain Security Act, improving supply chain efficiency and transparency, which should drive higher net margins and operating income over time.  Read the complete narrative. Curious what sits behind that fair value gap? The narrative leans on measured revenue growth, firmer margins and a richer future earnings multiple. The exact mix may surprise you. Result: Fair Value of $356.83 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, you should also keep an eye on pressure from lower fee generics and biosimilars, as well as weaker international specialty logistics, which could weigh on margins and earnings power. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page. Next Steps Mixed signals or an emerging opportunity, either way it pays to move quickly, review the full picture and weigh both the 5 key rewards and 1 important warning sign. Looking for more investment ideas? If you stop here, you risk missing other stocks that could better fit your goals, so use the tools available and stay one step ahead.  Target reliable income by scanning for companies screened as potential 9 dividend fortresses that might support a steadier cash return profile. Hunt for value by focusing on 49 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their business strength. Prioritize resilience by filtering for 61 resilient stocks with low risk scores so you can concentrate on companies with stronger overall risk profiles.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2641007179","isCrawlerRequest":true}